International Journal of Molecular and Immuno Oncology (IJMIO) is a peer-reviewed journal where clinicians and researchers can contribute and keep up with the fast-paced developments in Molecular Biology and Immuno oncology.The journal is owned by the Alms Tech LLP and published by Scientific Scholar(https://scientificscholar.com/)
In 2021 we received 28 manuscripts, of which 19 were accepted after rigorous peer -review and then published.
To date, we have had 591,992 full-text manuscript downloads from our journal website.
The most viewed manuscript is Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Year: 2021, Volume: 6, Issue: 1, January-April DOI:10.25259/IJMIO_30_2020
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.